NCT03654105 2026-03-27
SMILE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Active not recruiting
Clinical Trials
9 trialsNCT03568188 2026-02-24
FOCALE
Hospices Civils de Lyon
Phase 2 Completed
NCT06620835 2025-07-29
OPTALK
Groupe Francais De Pneumo-Cancerologie
Phase 2 Recruiting
NCT06454071 2024-06-12
Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients
Soonchunhyang University Hospital
Phase 2 Completed
NCT02346526 2022-09-29
A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer
Massachusetts General Hospital
Phase 2 Completed
NCT02839681 2019-05-21
Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT02560571 2016-09-20
Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients
Meir Medical Center
Phase 2 Unknown
NCT02288078 2014-11-13
Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)
Clinical Research Support Center Kyush
Phase 2 Unknown
NCT02280070 2014-10-31
RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).
Clinical Research Support Center Kyush
Phase 2 Unknown